Health Care: Drugs

Insmed Inc (INSM: NASDAQ)

$13.76 -0.24 | -1.71%
10/27/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 14.00
52 Week High 20.68
52 Week Low 9.02
Avg. Daily Vol. (Mil) 0.26
Beta (3 year) 1.22
Share Related Items
Mkt Cap (Mil) 866.29
Shares Out (Mil) 61.88
Float (Mil) 42.63
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.90
Current Ratio 7.10
LT Debt/ Equity 0.06
Total Debt / Equity 0.10
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 3.46
Price/Cash Flow -6.70
Per Share Data
Earnings -2.14
Sales 0.00
Book Value 4.05
Cash Flow -2.10
Business Summary
Insmed Inc is a biopharmaceutical company. The Company is developing ARIKAYCE for inhalation (LAI), for patients with nontuberculous mycobacteria lung disease, a rare and often chronic infection that is capable of causing irreversible lung damage.
General Information
10 Finderne Avenue
Building 10
Bridgewater, NJ 08807
Industry : Drugs
Sector: Health Care
Employees: 125
CEO: Mr. William H. Lewis
Short Interest
Current Month (Mil) 4.28
Previous Month (Mil) 4.18
Short Interest Ratio (Days) 16.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -44.20
Return on Investments -49.60
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with INSM

Latest INSM Headlines from TheStreet

More Financial News for INSM

Press Releases for INSM

See All Press Releases

Partner Headlines for INSM

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter